Dynex Cap is expected to report quarterly earnings at $0.33 per share on revenue of $31.78 million, while Summit Therapeutics is projected to report a quarterly loss at $0.08 per share on revenue of $56.92 million. Cleveland-Cliffs is estimated to report a quarterly loss at $0.46 per share on revenue of $4.89 billion, and HBT Financial is expected to report quarterly earnings at $0.62 per share on revenue of $60.07 million.
Dynex Capital (DX)
Dynex Capital reported quarterly earnings of $0.25 per share, missing the Zacks Consensus Estimate of $0.44 per share. This compares to a loss of $0.10 per share a year ago. The company's revenues for the quarter ended September 2025 were $30.61 million, surpassing the Zacks Consensus Estimate by 4.62%. Over the last four quarters, Dynex Capital has surpassed consensus EPS estimates just once. The stock has added about 5.8% since the beginning of the year versus the S&P 500's gain of 13.3%
Dynex Capital (DX) Lags Q3 Earnings Estimates[1].
Summit Therapeutics Inc. (SMMT)
Summit Therapeutics reported a quarterly adjusted loss of 31 cents per share for the quarter ended September 30, lower than the same quarter last year. The mean expectation of fifteen analysts for the quarter was for a loss of 13 cents per share. Reported revenue was zero; analysts expected zero. The company's shares have risen by 1.6% this quarter and gained 17.6% so far this year
Summit Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary[2].
Cleveland-Cliffs Inc. (CLF)
Cleveland-Cliffs is expected to report a quarterly loss at $0.46 per share on revenue of $4.89 billion. The company is a major steel producer and has been impacted by global steel market conditions. The exact earnings report is not yet available
HBT Financial (HBT) Surpasses Q3 Earnings and Revenue Estimates[3].
HBT Financial (HBT)
HBT Financial reported quarterly earnings of $0.65 per share, beating the Zacks Consensus Estimate of $0.62 per share. The company's revenues for the quarter ended September 2025 were $59.84 million, surpassing the Zacks Consensus Estimate by 0.06%. Over the last four quarters, HBT Financial has surpassed consensus EPS estimates four times. The stock has added about 7.8% since the beginning of the year versus the S&P 500's gain of 13.3% .
Comments
No comments yet